Drug intelligence / Profile preview

64Cu-CANF-comb

Development stage
Unknown
Lead developer
Washington University School of Medicine
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides, Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

**64Cu-CANF-comb** is an investigational, NPR-C-targeted polymeric comb nanoparticle PET radiotracer for molecular imaging of atherosclerotic plaque. It incorporates C-type atrial natriuretic factor peptide as the targeting ligand and copper-64 as the PET radionuclide; CANF binding enables imaging of natriuretic peptide clearance receptor expression in plaque-associated vascular smooth-muscle cells, endothelial cells, and macrophages. Preclinical studies showed receptor-specific plaque uptake and identified the 25% CANF-conjugated construct as the leading composition. The clinical program uses the specifically defined 64Cu-25%-CANF-Comb construct in PET/MRI studies of asymptomatic carotid artery stenosis. ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC5096390/))

Other names
64Cu-CANF-Comb[64Cu]CANF-comb
02

Targets

NPR3 (Natriuretic peptide receptor C)

Beyond the preview

Go deeper on 64Cu-CANF-comb.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 64Cu-CANF-comb.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call